drugset / Trial / NCT01231698

Heart Rate Control With Esmolol in Septic Shock

NCT01231698

Phase 2 Completed 154 enrolled Andrea Morelli
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is investigate the effects on systemic hemodynamics and organ function of esmolol when used to maintain heart rate below a predefined threshold in patients with septic shock.

Timeline

Start
2010-12
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Esmolol Other / unclassified Other